tiprankstipranks
SPO Global Inc. (SPOM)
OTHER OTC:SPOM
US Market

SPO Global (SPOM) Price & Analysis

20 Followers

SPOM Stock Chart & Stats

<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)

SPOM FAQ

What was SPO Global Inc.’s price range in the past 12 months?
Currently, no data Available
What is SPO Global Inc.’s market cap?
SPO Global Inc.’s market cap is $474.89K.
    When is SPO Global Inc.’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were SPO Global Inc.’s earnings last quarter?
    SPO Global Inc. released its earnings results on May 17, 2023. The company reported $0.002 earnings per share for the quarter.
      Is SPO Global Inc. overvalued?
      According to Wall Street analysts SPO Global Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does SPO Global Inc. pay dividends?
        SPO Global Inc. does not currently pay dividends.
        What is SPO Global Inc.’s EPS estimate?
        SPO Global Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does SPO Global Inc. have?
        SPO Global Inc. has 1,582,973,400 shares outstanding.
          What happened to SPO Global Inc.’s price movement after its last earnings report?
          SPO Global Inc. reported an EPS of $0.002 in its last earnings report. Following the earnings report the stock price went same N/A.
            Which hedge fund is a major shareholder of SPO Global Inc.?
            Currently, no hedge funds are holding shares in SPOM
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              SPO Global Inc.

              Established in 2006 and headquartered in Jinan, China, Gerpang Healthcare Group operates as a bio-pharmaceutical enterprise. The company focuses on developing and marketing a diverse range of products, including genetically coated stents, vaccines for the Hepatitis B virus (HBV), monoclonal antibodies designed to detect male infertility, functional foods targeting cognitive disorders, and polypeptide-based probiotics.

              SPO Global (SPOM) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              Singularity Future Technology
              SMX Public Limited Company
              Scage future
              Popular Stocks